Literature DB >> 16796384

Causes and consequences of methamphetamine and MDMA toxicity.

Maria S Quinton1, Bryan K Yamamoto.   

Abstract

Methamphetamine (METH) and its derivative 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) are 2 substituted amphetamines with very high abuse liability in the United States. These amphetamine-like stimulants have been associated with loss of multiple markers for dopaminergic and serotonergic terminals in the brain. Among other causes, oxidative stress, excitotoxicity and mitochondrial dysfunction appear to play a major role in the neurotoxicity produced by the substituted amphetamines. The present review will focus on these events and how they interact and converge to produce the monoaminergic depletions that are typically observed after METH or MDMA administration. In addition, more recently identified consequences of METH or MDMA-induced oxidative stress, excitotoxicity, and mitochondrial dysfunction are described in relation to the classical markers of METH-induced damage to dopamine terminals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16796384      PMCID: PMC3231568          DOI: 10.1007/bf02854904

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  94 in total

1.  Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP.

Authors:  D S Albers; G D Zeevalk; P K Sonsalla
Journal:  Brain Res       Date:  1996-04-29       Impact factor: 3.252

Review 2.  Excitatory amino acids as a final common pathway for neurologic disorders.

Authors:  S A Lipton; P A Rosenberg
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

3.  Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.

Authors:  J E Malberg; K E Sabol; L S Seiden
Journal:  J Pharmacol Exp Ther       Date:  1996-07       Impact factor: 4.030

4.  D-amphetamine-induced depletion of energy and dopamine in the rat striatum is attenuated by nicotinamide pretreatment.

Authors:  F J Wan; H C Lin; B H Kang; C J Tseng; C S Tung
Journal:  Brain Res Bull       Date:  1999-10       Impact factor: 4.077

5.  Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.

Authors:  J F Nash; B K Yamamoto
Journal:  Brain Res       Date:  1992-05-29       Impact factor: 3.252

6.  The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole.

Authors:  A R Green; R J De Souza; J L Williams; T K Murray; A J Cross
Journal:  Neuropharmacology       Date:  1992-04       Impact factor: 5.250

7.  The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones.

Authors:  M I Colado; A R Green
Journal:  Eur J Pharmacol       Date:  1995-07-14       Impact factor: 4.432

8.  Effects of glutamate antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine-induced striatal dopamine release in vivo.

Authors:  K T Finnegan; T Taraska
Journal:  J Neurochem       Date:  1996-05       Impact factor: 5.372

9.  Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade.

Authors:  G D Zeevalk; E Derr-Yellin; W J Nicklas
Journal:  J Pharmacol Exp Ther       Date:  1995-12       Impact factor: 4.030

10.  Neurochemical basis of neurotoxicity.

Authors:  J W Gibb; M Johnson; G R Hanson
Journal:  Neurotoxicology       Date:  1990       Impact factor: 4.294

View more
  88 in total

Review 1.  Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage.

Authors:  Byoung-Joon Song; Kwan-Hoon Moon; Vijay V Upreti; Natalie D Eddington; Insong J Lee
Journal:  Curr Pharm Biotechnol       Date:  2010-08       Impact factor: 2.837

2.  Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings.

Authors:  Mariana Cherner; Chad Bousman; Ian Everall; Daniel Barron; Scott Letendre; Florin Vaida; J Hampton Atkinson; Robert Heaton; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2010-08-23       Impact factor: 2.892

3.  Using blood brain barrier disruption by methamphetamine for drug delivery.

Authors:  R E Kast
Journal:  J Neurooncol       Date:  2007-04-27       Impact factor: 4.130

4.  Concurrence of autophagy with apoptosis in alveolar epithelial cells contributes to chronic pulmonary toxicity induced by methamphetamine.

Authors:  Yun Wang; Yu-Han Gu; Li-Ye Liang; Ming Liu; Bin Jiang; Mei-Jia Zhu; Xin Wang; Lin Shi
Journal:  Cell Prolif       Date:  2018-06-28       Impact factor: 6.831

Review 5.  Neuroimaging of children following prenatal drug exposure.

Authors:  Chris Derauf; Minal Kekatpure; Nurunisa Neyzi; Barry Lester; Barry Kosofsky
Journal:  Semin Cell Dev Biol       Date:  2009-03-13       Impact factor: 7.727

Review 6.  Fetal effects of psychoactive drugs.

Authors:  Amy L Salisbury; Kathryn L Ponder; James F Padbury; Barry M Lester
Journal:  Clin Perinatol       Date:  2009-09       Impact factor: 3.430

7.  Adding fuel to the fire: methamphetamine enhances HIV infection.

Authors:  Raghava Potula; Yuri Persidsky
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

8.  Additive Effects of Former Methylenedioxymethamphetamine and Cannabis Use on Subclinical Psychotic Symptoms.

Authors:  Berker Duman; Nilay Sedes; Bora Baskak
Journal:  Noro Psikiyatr Ars       Date:  2017-03-01       Impact factor: 1.339

9.  Methamphetamine alters blood brain barrier protein expression in mice, facilitating central nervous system infection by neurotropic Cryptococcus neoformans.

Authors:  Eliseo A Eugenin; Jade M Greco; Susana Frases; Joshua D Nosanchuk; Luis R Martinez
Journal:  J Infect Dis       Date:  2013-03-26       Impact factor: 5.226

10.  Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum.

Authors:  Despina A Tata; Bryan K Yamamoto
Journal:  Synapse       Date:  2008-05       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.